DECONEX IR- guaifenesin and phenylephrine hydrochloride tablet
Poly Pharmaceuticals, Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
(in each tablet)
Guaifenesin 380 mg
Phenylephrine HCl 10 mg
Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
Do not exceed recommended dosage.
| Adults and children|
12 years of age and over:
| 1 tablet every 4 hours, not to
exceed 6 tablets in 24 hours.
| Children 6 to under 12|
years of age:
| 1/2 tablet every 4 hours, not to
exceed 3 tablets in 24 hours.
| Children under|
6 years of age:
| Consult a physician.
Store at controlled room temperature between 15°- 30°C (59°- 86°F).
Supplied in a tight, light-resistant container with a child-resistant cap.
Contains color additives including FD&C Yellow No. 5 (tartrazine).
Deconex IR Tablets are green, oval-shaped, scored tablets, debossed "POLY" bisect "716" on one side, and plain on the other side.
colloidal silicon dioxide, croscarmellose sodium, FD&C Blue #1 aluminum lake, FD&C Yellow #5 aluminum lake, hypromellose, maltodextrin, povidone, silicified microcrystalline cellulose, and stearic acid.
Quitman, MS 39355
1 (800) 882-1041
The packaging below represents the labeling currently used.
Principal display panel and side panel for 60 tablets label:
EXPECTORANT · NASAL DECONGESTANT
Each tablet contains:
Phenylephrine HCl......................10 mg
Tamper evident by foil seal under cap.
Do not use if foil seal is broken or missing.
Quitman, MS 39355
guaifenesin, phenylephrine hydrochloride tablet
|Labeler - Poly Pharmaceuticals, Inc. (198449894)|